KR101151365B1 - Nano-emulsion composition using the high-pressure homogenizer - Google Patents

Nano-emulsion composition using the high-pressure homogenizer Download PDF

Info

Publication number
KR101151365B1
KR101151365B1 KR1020050135139A KR20050135139A KR101151365B1 KR 101151365 B1 KR101151365 B1 KR 101151365B1 KR 1020050135139 A KR1020050135139 A KR 1020050135139A KR 20050135139 A KR20050135139 A KR 20050135139A KR 101151365 B1 KR101151365 B1 KR 101151365B1
Authority
KR
South Korea
Prior art keywords
coenzyme
pressure homogenizer
composition
high pressure
weight
Prior art date
Application number
KR1020050135139A
Other languages
Korean (ko)
Other versions
KR20070071572A (en
Inventor
정원욱
김기선
이천구
윤명석
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1020050135139A priority Critical patent/KR101151365B1/en
Publication of KR20070071572A publication Critical patent/KR20070071572A/en
Application granted granted Critical
Publication of KR101151365B1 publication Critical patent/KR101151365B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/068Microemulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81Preparation or application process involves irradiation

Abstract

본 발명은 고압 호모지나이저를 이용한 나노유화 조성물에 관한 것으로서, 보다 상세하게는 고압 호모지나이저에 의해 코엔자임 Q10 0.01 내지 30 중량%, 유화제인 수소첨가 레시친 1 내지 10 중량%, 산화 방지제로서 토코페롤을 0.1 내지 1.0 중량%, 및 분산매로서 잔량의 글리세린을 포함하는 유화 조성물을 제조함으로써, 입자크기가 균일하고 미세하여 안정한 고압 호모지나이저를 이용한 나노유화 조성물에 관한 것이다.The present invention relates to a nanoemulsifying composition using a high pressure homogenizer, and more particularly, 0.01 to 30% by weight of coenzyme Q10, 1 to 10% by weight of hydrogenated lecithin, which is an emulsifier, and tocopherol as an antioxidant by a high pressure homogenizer. The present invention relates to a nanoemulsion composition using a high pressure homogenizer having a stable, fine and stable particle size by preparing 0.1 to 1.0% by weight and a residual amount of glycerin as a dispersion medium.

코엔자임 Q-10, 수소첨가 레시친, 고압 호모지나이저 Coenzyme Q-10, Hydrogenated Lecithin, High Pressure Homogenizer

Description

고압 호모지나이저를 이용한 나노유화 조성물{NANO-EMULSION COMPOSITION USING THE HIGH-PRESSURE HOMOGENIZER}Nanoemulsification composition using high pressure homogenizer {NANO-EMULSION COMPOSITION USING THE HIGH-PRESSURE HOMOGENIZER}

본 발명은 코엔자임 Q10을 함유한 나노유화 조성물에 관한 것으로서, 더욱 상세하게는 고압 호모지나이저를 이용하여 균일하고 미세한 나노크기의 매우 안정한 유화 조성물을 제조할 수 있는 고압 호모지나이저를 이용한 나노유화 조성물에 관한 것이다.The present invention relates to a nanoemulsion composition containing coenzyme Q10, and more particularly to a nanoemulsion composition using a high-pressure homogenizer capable of producing a uniform and fine nano-size highly stable emulsion composition using a high-pressure homogenizer. It is about.

코엔자임 Q10(Coenzyme Q)은 호흡대사인 전자전달계에서 플라빈 단백질과 시토크롬 b 사이의 전자전달을 매개하는 역할을 하는 강력한 항산화제로서, 자유 라디칼(free radicals)로부터 발생될 수 있는 여러 가지 체내 손상을 억제시켜준다(Grossi et al.,1992). 특히 코엔자임 Q10은 에너지 생성기관인 미토콘드리아에 가장 많이 존재하여 각 세포 안의 미토콘드리아가 제 기능을 하기 위해서 꼭 필요한 물질이다. 이 물질은 체내에 널리 분포한다는 뜻으로 유비퀴논(Ubiquinone : ubiquitous + quinone, 생물체에 보편적으로 존재하는 퀴논)이라고 불린다(Concise Encyclopedia Biochemistry, Second Edition, Walter de Gruyter Berlin. New York 1988, p619). 또한, 벤조퀴논의 골격에 결합하는 이소프레노이드 곁사슬이 n=10인 유비데카레논(Ubidecarenone)은 사람에 존재하는 유비퀴논으로서 코엔자임 Q10이라고 불린다.Coenzyme Q is a powerful antioxidant that mediates electron transfer between flavin protein and cytochrome b in the respiratory metabolic electron transport system. It is responsible for the various body damage that can occur from free radicals. Inhibition (Grossi et al., 1992). In particular, coenzyme Q10 is present in the mitochondria, the energy generator, and is essential for the function of mitochondria in each cell. This substance is called ubiquinone (ubiquitous + quinone), which means it is widely distributed in the body (Concise Encyclopedia Biochemistry, Second Edition, Walter de Gruyter Berlin.New York 1988, p619). In addition, Ubidecarenone having an isoprenoid side chain n = 10 bound to the skeleton of benzoquinone is called coenzyme Q10 as a ubiquinone present in humans.

코엔자임 Q-10을 합성하는 신체의 능력은 30대 중반부터 감소되기 시작하며, 그 수치가 떨어지면 건강을 해칠 수 있다고 한다. 코엔자임 Q-10의 결핍 부분을 보충해 주면 신체 기관이 제 기능을 하고 신체의 총체적인 건강이 회복되는데 도움이 된다는 보고가 많이 있다. 유럽과 미국에서는 10년 전부터 화제가 되어 1998년 세계 최초로 독일의 바이어스도르프가 코엔자임 Q-10을 배합한 주름 개선 크림을 발매하였다. 일본 후생성에서는 1974년 울혈성심부전의 약제로 코엔자임 Q10의 사용을 인가한 이래, 2001년에는 영양보조식품 등 식품에 개방했으며, 최근에는 화장품 성분으로 인정하였다.The body's ability to synthesize coenzyme Q-10 begins to decline in its mid-30s, and if that number drops, it can hurt your health. There are many reports that supplementing the deficiency of coenzyme Q-10 can help your organs function and restore your body's overall health. In Europe and the United States, it became a hot topic 10 years ago, and in 1998, Germany's Beiersdorf launched the anti wrinkle cream containing Coenzyme Q-10. Since the Ministry of Health, Labor and Welfare approved the use of coenzyme Q10 as a drug for congestive heart failure in 1974, it has been open to foods such as nutritional supplements in 2001 and recently recognized as a cosmetic ingredient.

코엔자임 Q-10은 콜라게나아제의 생성을 억제하여 광노화를 막는 효과가 있다(Coenzyme Q10, a cutaneous antioxdant and energizer. Bilfactors. 9(1999) p371-378, Paul Gerson Unna Research Center, Beiersdorf AG, Hamburg, Germany). 또한, 코엔자임 Q-10의 오랜 사용이 눈가의 주름을 감소시킨다는 보고도 있다 (Modulation of oxidative stresses in human aging skin, Z Gerontol Geriatr. 32(1999), p83-88).Coenzyme Q-10 has the effect of inhibiting collagenase production to prevent photoaging (Coenzyme Q10, a cutaneous antioxdant and energizer. Bilfactors. 9 (1999) p371-378, Paul Gerson Unna Research Center, Beiersdorf AG, Hamburg, Germany). In addition, long-term use of coenzyme Q-10 has been reported to reduce wrinkles around the eyes (Modulation of oxidative stresses in human aging skin, Z Gerontol Geriatr. 32 (1999), p83-88).

그러나, 코엔자임 Q10은 노란색의 분말로서 공기중에서 불안정하며, 물에 대한 용해성이 매우 약하다. 특히, 이것은 화장료 기제에 대해 불용성을 나타내어 제형화에 어려움이 많다. 이에, 불용성인 코엔자임 Q10을 화장료에 도입하고자 하는 노력이 있어 왔다. 이에 따라, 유효 성분을 안정하게 포집한 상태로 제형화 과 정을 거쳐, 실제 적용시 효과적으로 내부의 활성 성분을 방출하는 나노기술에 대한 필요성을 점차 증가하고 있다.However, Coenzyme Q10 is a yellow powder, unstable in air, and very poorly soluble in water. In particular, it is insoluble in cosmetic bases and is difficult to formulate. Thus, there have been efforts to introduce insoluble coenzyme Q10 into cosmetics. Accordingly, there is a growing need for nanotechnology to effectively release the active ingredient inside the formulation through the formulation process in a stable collection of the active ingredient.

예를 들면, 한국공개특허 제10-2005-0054012호는 자기회합성 고분자 나노입자를 제조하는 방법을 개시하였다. 그러나, 상기 방법은 코엔자임 Q10을 용해시키기 위해 유기용매를 사용해야 하는 문제가 있다.For example, Korean Laid-Open Patent Publication No. 10-2005-0054012 discloses a method of manufacturing self-associating polymer nanoparticles. However, this method has a problem of using an organic solvent to dissolve coenzyme Q10.

한국특허공개 제2002-0080370호는 시클로덱스트린을 이용한 나노 복합체의 제조방법을 개시하고 있다. 또한, 미국특허 제6,107,276호는 TWEEN-80을 이용한 코엔자임 Q10입자 제조를 개시하고 있고, 미국특허 제 4,869,900호는 레시친과 수소화된 팜 오일(HYDROGENATED PALM OIL)의 모노글리세라이드, 디글리세라이드, 트리글리세라이드 및 폴리에틸렌 글리콜의 팔미테이트-스테아레이드를 함께 사용하여 코엔자임 Q10을 캡슐화시키고 있다. 그러나, 상기 방법들은 입자 크기가 커서 경피흡수가 빠르지 못하다는 문제점이 있다.Korean Patent Publication No. 2002-0080370 discloses a method for preparing a nanocomposite using cyclodextrin. In addition, US Pat. No. 6,107,276 discloses the preparation of coenzyme Q10 particles using TWEEN-80, while US Pat. No. 4,869,900 discloses monoglycerides, diglycerides, triglycerides of lecithin and hydrogenated palm oil. And palmitate-stearate of polyethylene glycol are used together to encapsulate coenzyme Q10. However, these methods have a problem that the percutaneous absorption is not fast due to the large particle size.

또한, 미국특허 제5,443,842호는 PEG-40 수소화된 캐스터 오일(HYDROGENATED CASTOR OIL)을 이용하는 방법이 개시되어 있으나, 상기 방법은 제조공정이 복잡하며 시간이 오래 걸리는 문제가 있다.In addition, U. S. Patent No. 5,443, 842 discloses a method using PEG-40 hydrogenated castor oil, but the method has a complicated manufacturing process and takes a long time.

한편, 일반적으로 레시친 자체는 특이취 및 경시안정성이 좋지 않고 과산화물값(POV, peroxide Value)이 높기 때문에 화장품 원료로 적용하기 곤란하다. 따라서, 레시친에 촉매를 이용하여 수소첨가를 하여 레시친의 불포화지방산이 포화지방산으로 바뀌게 되는 수소첨가 레시친을 이용하고 있다. 상기 수첨레시친은 레시친과는 달리 안정성(냄새, POV값 등)이 개선되어 화장품에 사용하기 적합하고 피부 에 대한 안정성이 우수하다고 연구되어져 있다 (Kutz G., Biehi P., Waldmann-Laue M., Jackwerth B., SOFW-Journal, 123, 145-149(1997))). 이때, 과산화물값 측정을 위해 시간 경과에 따른 안정성 측정법으로 자동산화 측정 방법을 이용하며, 이는 시간 경과에 따른 POV와 카르보닐값(COV, Carbonyl Value)을 모니터링하여 구한다. 여기에서 POV란 원료 자체의 자동 산화에 대한 측정값으로 경시에 따른 과산화물가를 측정하는 것을 말하고, COV란 카르보닐 값을 측정하는 것이다(일본 영양 식량학회지 Vol.39,No.5, P391(1986)).On the other hand, in general, lecithin itself is difficult to apply as a cosmetic raw material because the specific odor and seizure stability is not good and the peroxide value (POV, high) is high. Therefore, hydrogenated lecithin is used in which the lecithin is hydrogenated using a catalyst to convert the unsaturated fatty acid of the lecithin into a saturated fatty acid. Unlike the lecithin, the hydrogenated lecithin has been studied to improve stability (odor, POV value, etc.), which is suitable for use in cosmetics and excellent in skin stability (Kutz G., Biehi P., Waldmann-Laue M., Jackwerth B., SOFW-Journal, 123, 145-149 (1997)). In this case, an automatic oxidation measurement method is used as a measure of stability over time to measure peroxide value, which is obtained by monitoring POV and carbonyl value (COV) over time. Here, POV refers to the measurement of peroxide value as a measure of the automatic oxidation of the raw material itself, and COV refers to the measurement of carbonyl value (Japanese Society for Nutrition and Food Science Vol. 39, No. 5, P391 (1986)). ).

그러나 종래 수첨레시친을 이용한 유화형 제품은 수첨레시친을 주유화제로 사용한 경우 일반 비이온 계면활성제보다 계면장력이 저하되거나 유화능력이 떨어져 주로 보조적으로 사용하여 왔다. 또한 천연에 대한 관심이 높아지고 피부의 안전성 면에서도 천연유화제에 대한 관심이 커짐에 따라서 레시친과 같은 천연유화제를 사용한 유화 조성물이 많이 개발되었다. 하지만, 천연유화제인 레시친의 유화능력은 일반 유화제보다 계면장력이 크고, HLB(Hydrophilic Lipophilic Balance) 값이 8정도 밖에 되지 않아서 유화 능력이 떨어지므로 일반 유화방법으로는 그 유화물을 안정화시키기는 어려워서 일정 이상의 기계적인 힘을 가해야만 유화제인 수첨레시친이 분자 회합체 형태를 생성시키고 입자를 형성하면서 입자 크기를 작게 하였다.However, conventionally emulsified products using hydrogenated lecithin have been mainly used as auxiliary agents due to lowering of interfacial tension or lower emulsification ability than ordinary nonionic surfactants when hydrogenated lecithin is used as an oiling agent. In addition, as interest in nature increases and interest in natural emulsifiers in terms of safety of the skin increases, many emulsion compositions using natural emulsifiers such as lecithin have been developed. However, the emulsification ability of natural emulsifier lecithin has greater interfacial tension than general emulsifiers, and the emulsification capacity is reduced by only about 8 HLB (Hydrophilic Lipophilic Balance), so it is difficult to stabilize the emulsion by a general emulsification method. Only mechanical force was applied to emulsify hydrogenated lecithin to form molecular aggregates and form particles, reducing the particle size.

또한, 한국등록특허 제0500643호는 나노유화입자 총 중량에 대하여 아스코빌 테트라이소팔미테이트 0.05 ~ 10.0 중량%, 코엔자임 Q-10 0.1 ~ 10.0 중량%, 및 토코페롤 0.01 ~ 10.0 중량%를 함유하고, 유화제로서 레시틴 3~10 중량%를 첨가하여 제조한 나노유화입자를 함유하는 항산화용 피부 외용제 조성물을 개시하고 있다. 또한, 한국특허공개 제2001-0075886호에서는 고압호모지나이저와 수첨레시친을 이용한 화장료용 유화 조성물이 개시된 바 있다. 그러나, 상기 방법들에서는 분산매로서 물을 사용하므로 입자크기 100 nm 이상의 불안정한 유화입자가 형성되는 문제가 있다. 즉, 일반적으로 분산매로서 보습제나 정제수를 사용할 경우 입자크기가 커지고 안정성이 떨어진다.In addition, Korean Patent No. 0500643 contains 0.05 to 10.0 wt% of ascorbyl tetraisopalmitate, 0.1 to 10.0 wt% of coenzyme Q-10, and 0.01 to 10.0 wt% of tocopherol, based on the total weight of nanoemulsion particles, and an emulsifier. As an anti-oxidant skin external composition comprising nanoemulsified particles prepared by adding 3 to 10 wt% of lecithin as an antimicrobial agent. In addition, Korean Patent Publication No. 2001-0075886 discloses an emulsion composition for cosmetics using a high pressure homogenizer and hydrogenated lecithin. However, in the above methods, since water is used as the dispersion medium, unstable emulsified particles having a particle size of 100 nm or more are formed. That is, in general, when a moisturizing agent or purified water is used as the dispersion medium, the particle size becomes large and stability is low.

상기 종래기술의 문제점을 해결하기 위하여, 본 발명의 목적은 물과 유기용매를 사용하지 않으며 간단한 제조 방법으로 100nm이하 정도의 크기로 투명하고 안정한 입자를 제조할 수 있는 고압 호모지나이저를 이용한 나노유화 조성믈 제공하기 위한 것이다.In order to solve the problems of the prior art, an object of the present invention is to use nanoemulsification using a high pressure homogenizer that can produce transparent and stable particles with a size of about 100 nm or less by using a simple manufacturing method without using water and organic solvents It is to provide the composition.

상기 목적을 달성하기 위하여, 본 발명은 코엔자임 Q10 0.01 내지 30 중량%, 유화제인 수소첨가 레시친 1 내지 10 중량%, 산화 방지제로서 토코페롤을 0.1 내지 1.0 중량%, 및 분산매로서 잔량의 글리세린을 포함하는 나노유화 조성물을 제공한다.In order to achieve the above object, the present invention provides nanoparticles containing 0.01 to 30% by weight of coenzyme Q10, 1 to 10% by weight of hydrogenated lecithin, which is an emulsifier, 0.1 to 1.0% by weight of tocopherol as an antioxidant, and a residual amount of glycerin as a dispersion medium. It provides an emulsion composition.

또한, 본 발명은 점도 50 내지 3000cps이고, 입자크기 100 nm이하인 상기한 구성을 갖는 나노유화 조성물을 이용하여 제조된 화장료를 제공한다.In addition, the present invention provides a cosmetic prepared by using a nanoemulsified composition having the above-mentioned composition having a viscosity of 50 to 3000 cps and a particle size of 100 nm or less.

이하에서 본 발명을 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명자들은 코엔자임 Q10의 불용성 문제를 해결하기 위해, 유화제로서 수소첨가 레시친을 사용하고, 산화방지제인 토코페롤의 분산매로 글리세린을 사용하였으며, 고압 호모지나이저를 이용하여 제조공정이 간편하고 입자크기가 균일하고 미세한 나노크기의 매우 안정한 유화 조성물을 제조함으로써, 본 발명을 완성하였다.The present inventors used hydrogenated lecithin as an emulsifier to solve the insolubility problem of coenzyme Q10, glycerin as a dispersion medium of tocopherol as an antioxidant, and using a high pressure homogenizer, the manufacturing process is simple and the particle size is uniform. The present invention was completed by preparing a fine, nano-sized, very stable emulsion composition.

본 발명의 유화 조성물에서, 코엔자임 Q10의 사용함량은 목적과 경우에 따라 조절될 수 있다. 바람직하게는 상기 코엔자임 Q10의 함량이 30 중량%를 초과하는 경우 효과적인 포집이 불가능하여 유효 성분의 입자 밖으로 유출되어 결정형으로 응집되거나 변성 원인이 될 수 있는 점을 고려하여, 전체 조성물에 대해 0.01 내지 30 중량%로 사용하는 것이 좋다.In the emulsion composition of the present invention, the content of coenzyme Q10 can be adjusted according to the purpose and the case. Preferably, when the content of the coenzyme Q10 exceeds 30% by weight, effective collection is not possible, and may be caused to flow out of the particles of the active ingredient, causing aggregation or degeneration in the crystalline form. It is recommended to use in weight percent.

상기 유화제인 수소첨가 레시친의 함량은 전체 조성물에 대해 0.1 내지 20 중량%, 바람직하게는 1 내지 10 중량%로 사용한다. 본 발명에서 유화제로 사용하는 수첨레시친이란, 레시친에 수소를 첨가시킨 레시친을 의미하는 것으로서, 레시친에 촉매를 이용한 수소첨가를 통해 제조된 것을 사용한다.The content of the hydrogenated lecithin as the emulsifier is used in an amount of 0.1 to 20% by weight, preferably 1 to 10% by weight based on the total composition. The hydrogenated lecithin used as an emulsifier in the present invention means a lecithin to which hydrogen has been added to the lecithin, and one prepared by hydrogenation using a catalyst in the lecithin is used.

상기 토코페롤은 유용성 산화방지제로 사용되며, 그 함량은 전체 조성물에 대해 0.01 내지 5 중량%, 바람직하게는 0.1 내지 1.0 중량%로 사용한다.The tocopherol is used as an oil-soluble antioxidant, the content is used in 0.01 to 5% by weight, preferably 0.1 to 1.0% by weight based on the total composition.

특히, 본 발명에서는 종래와 같이 분산매로서 물을 사용하지 않고, 글리세린을 사용하여, 입자크기를 작게 형성할 수 있고 유화입자의 안정성을 향상시키는 특징이 있다. 상기 글리세린의 함량은 전체 유화 조성물에 대해 잔량으로 포함한다.In particular, in the present invention, the particle size can be made small by using glycerin without using water as a dispersion medium as in the prior art, and there is a feature of improving the stability of the emulsified particles. The content of glycerin is included in the remaining amount relative to the total emulsion composition.

또한, 본 발명에서는 유화조성물 제조시 고압 호모지나이저를 사용함으로 써, 종래보다 유화능을 상승시켜 조성물 중의 입자들이 균일하고 미세한 나노크기를 가지면서 안정하게 한다.In addition, in the present invention, by using a high pressure homogenizer in the preparation of the emulsion composition, by increasing the emulsification capacity than the prior art to stabilize the particles in the composition having a uniform and fine nano-size.

본 발명의 유화조성물의 제조방법은, 상기 성분들을 포함하는 유화 조성물을 호모믹서에서 1차 유화시키고, 이를 고압 호모지나이저에 1회 이상 통과시켜 2차 유화시켜 균일하고 미세한 나노크기의 매우 안정한 유화 조성물을 제공할 수 있다. 상기 고압 호모지나이저의 압력은 50~2500 기압의 고압, 바람직하게는 200~1000 기압이다.In the method for preparing an emulsion composition of the present invention, the emulsion composition including the above components is firstly emulsified in a homomixer, and then passed through the high-pressure homogenizer one or more times to be secondly emulsified to provide a very stable emulsion having a uniform and fine nano size. A composition can be provided. The pressure of the high pressure homogenizer is a high pressure of 50 to 2500 atmospheres, preferably 200 to 1000 atmospheres.

상기 고압 호모지나이저란 고압 이용 유화라고 하며, 일반적인 교반기나 호모믹서로 1차 유화시킨 유화물을 고압 호모지나이저(Homogenizer)를 통과시켜 2차 유화를 시키는 것을 말한다. 이때, 오일 입자가 미립화되는 과정은 높은 압력에서 상압 1기압으로 유화물이 통과할 때 생기는 압력변동, 캐비테이션(Cavitation), 충돌력으로 유화입자를 작게 만드는 것이다. 유화물을 제조할 때 호모지나이저의 유화능력을 에너지로 환산하면 일반 호모믹서 보다 약 10,000배 정도 크다고 할 수 있다(Encyclopedia of Emulsion Technology, Vol 1, page 97(19830).The high pressure homogenizer is called high pressure emulsification, and refers to the second emulsification by passing an emulsion emulsified primarily by a general stirrer or a homomixer through a high pressure homogenizer. At this time, the process of atomizing the oil particles is to make the emulsified particles small by the pressure fluctuation, cavitation, impact force generated when the emulsion passes from the high pressure to atmospheric pressure 1 atm. When the emulsion is prepared, the homogenizer's emulsifying capacity is converted into energy, which is about 10,000 times larger than a general homomixer (Encyclopedia of Emulsion Technology, Vol 1, page 97 (19830)).

이러한 방법으로 제조된 본 발명의 유화 조성물의 입자크기는 100 nm이하, 바람직하게는 20 내지 80 nm이며, 점도는 50 내지 3000 cps이 된다.The particle size of the emulsion composition of the present invention prepared by this method is 100 nm or less, preferably 20 to 80 nm, the viscosity is 50 to 3000 cps.

본 발명의 유화조성물은 입자크기가 미세하고 균일할 뿐 아니라, 투명하고 점도가 낮기 때문에 스킨류, 로션류 및 크림류 등의 다양한 화장료 제형에 적용이 가능하다.The emulsion composition of the present invention can be applied to various cosmetic formulations such as skins, lotions and creams because the particle size is not only fine and uniform, but also transparent and low in viscosity.

이하 본 발명을 실시예에 의해 더욱 상세히 설명하지만, 이들 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위가 하기 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but these Examples are only for illustrating the present invention, and the scope of the present invention is not limited by the following Examples.

실시예Example 1 내지 4 및  1 to 4 and 비교예Comparative example 1 내지 6 1 to 6

다음 표 1의 조성 및 함량으로 실시예 1 내지 4 및 비교예 1 내지 6의 유화 조성물을 제조하였다. 유화조성물의 제조방법은, 수첨레시친과 코엔자임 Q10, 토코페롤, 글리세린을 혼합하고, 70℃로 가온 교반하여 균일하게 만들어 1차 유화시킨 후, 상기 1차 유화물을 고압 호모지나이저에 통과시켜 2차 유화시켜 유화조성물을 제조하였다. 고압호모게아니저의 사용 압력은 50~25000 기압이나, 여기서는 200~1000 기압에서 1회 통과시켜 냉각하였다.The emulsion compositions of Examples 1 to 4 and Comparative Examples 1 to 6 were prepared according to the compositions and contents of Table 1 below. In the method of preparing the emulsion composition, hydrogenated lecithin, coenzyme Q10, tocopherol, and glycerin are mixed, heated to 70 ° C., uniformly stirred to make the first emulsion, and then the primary emulsion is passed through a high pressure homogenizer to undergo secondary emulsion. To prepare an emulsion composition. The working pressure of the high pressure homogenizer was 50 to 25000 atm, but it was cooled by passing once at 200 to 1000 atm.

[표 1][Table 1]

구분(중량%)Category (% by weight) 실시예1Example 1 실시예2Example 2 실시예3Example 3 실시예4Example 4 실시예5Example 5 비교예1Comparative Example 1 비교예2Comparative Example 2 비교예3Comparative Example 3 비교예4Comparative Example 4 비교예5Comparative Example 5 글리세린glycerin To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 수첨레시친Hydrogen Lecithin 1.01.0 3.03.0 5.05.0 5.05.0 5.05.0 5.05.0 -- -- 5.05.0 5.05.0 코엔자임 Q10Coenzyme Q10 1.01.0 1.01.0 1.01.0 2.02.0 3.03.0 -- 2.02.0 -- 2.02.0 -- 토코페롤Tocopherol 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 -- -- 0.20.2 -- 0.20.2

(실험예)Experimental Example

상기 실시예 및 비교예에서 제조된 코엔자임 Q10 함유 나노유화 조성물의 온도 안정성 및 입자 평균크기와 나노유화 조성물 내의 코엔자임 Q10 장기보관 안정성을 다음과 같은 방법으로 측정하였다.Temperature stability and average particle size and coenzyme Q10 long-term storage stability of the coenzyme Q10-containing nanoemulsion composition prepared in Examples and Comparative Examples were measured by the following method.

1) 코엔자임 Q10 함유 나노유화 조성물의 온도 안정성 평가1) Temperature Stability Evaluation of Coenzyme Q10-Containing Nanoemulsified Compositions

상기 제조된 각각의 실시예 및 비교예의 유화 조성물을 50 ℃, 0 ℃, cycle(-10℃ 1일 → 45 1일→ -10℃ 1일의 사이클)의 조건에서 1개월간 보관 후, 분리 및 외관 변화, 입자 크기의 변화 등의 상태를 관찰하여 매우 양호(◎), 양호(○), 약간 분리(△), 완전분리(×)로 안정성을 평가하고, 그 결과를 표 2에 나타내었다.The emulsion compositions of each of Examples and Comparative Examples prepared above were stored for 1 month under the conditions of 50 ° C., 0 ° C., and cycle (-10 ° C. 1 day → 45 1 day → -10 ° C. 1 day cycle), followed by separation and appearance. Changes, changes in particle size, and the like were observed to evaluate the stability as very good (◎), good (○), slightly separated (△), and completely separated (×), and the results are shown in Table 2.

[표 2]TABLE 2

구분division 실시예1Example 1 실시예2Example 2 실시예3Example 3 실시예4Example 4 실시예5Example 5 비교예1Comparative Example 1 비교예2Comparative Example 2 비교예3Comparative Example 3 비교예4Comparative Example 4 비교예5Comparative Example 5 50℃50 ℃ ×× ×× 25℃25 ℃ ×× ×× 0℃0 ℃ ×× ×× cyclecycle ×× ××

2) 코엔자임 Q 10 함유 나노유화 조성물의 입자 평균크기 측정2) Measurement of particle average size of coenzyme Q 10 containing nanoemulsified composition

상기 제조된 각각의 실시예 및 비교예의 유화 조성물물의 입자 평균크기는 일반적으로 사용하는 입도 분석기(Particle Sizer)를 이용하여 제조 직후 측정하고, 그 결과를 표 3에 나타내었다.The particle average size of each of the prepared emulsion and comparative examples was measured immediately after preparation using a commonly used particle size analyzer (Particle Sizer), and the results are shown in Table 3.

[표 3][Table 3]

구분division 평균직경(nm)Average diameter (nm) 실시예1Example 1 240.4240.4 실시예2Example 2 38.138.1 실시예3Example 3 35.235.2 실시예4Example 4 60.860.8 실시예5Example 5 118.5118.5 비교예1Comparative Example 1 34.534.5 비교예2Comparative Example 2 측정불가Not measurable 비교예3Comparative Example 3 측정불가Not measurable 비교예4Comparative Example 4 60.660.6 비교예5Comparative Example 5 38.638.6

3) 나노유화 조성물 내의 코엔자임 Q10 장기보관 안정성 평가3) Evaluation of long-term storage stability of coenzyme Q10 in nanoemulsifying composition

상기 제조된 각각의 실시예 및 비교예의 코엔자임 Q10 함유 나노유화 조성물의 장기보관 안정성을 확인하였다. HPLC(HP-1100, HEWLETT PACKARD Co.)를 이용하여 코엔자임 Q10 함량을 측정하여 그 결과를 표 4에 나타내었다.The long-term storage stability of the coenzyme Q10-containing nanoemulsion composition of each of the above-prepared examples and comparative examples was confirmed. Coenzyme Q10 content was measured using HPLC (HP-1100, HEWLETT PACKARD Co.) and the results are shown in Table 4.

(측정방법)(How to measure)

코엔자임 Q10으로서 약 3mg 해당량을 정밀하게 달아 에탄올에 녹여 100ml를 만들고, 초음파 처리한 후 0.45㎛ 여과막을 통과시켜 검액으로 사용하였다. 별도로, 코엔자임 Q10 표준품 3mg을 정밀하게 달아 에탄올에 녹여 100ml로 하여 표준액으로 사용하였다. 상기 검액 및 표준액 30㎕ 씩을 사용하여, 다음 조건으로 액체크로마토그래프법에 따라 시험하여 코엔자임 Q10 의 피크면적으로 구하였다.About 3mg of Coenzyme Q10 was precisely weighed and dissolved in ethanol to make 100ml. After sonication, a 0.45㎛ filtration membrane was used as the sample solution. Separately, 3 mg of coenzyme Q10 standard was precisely weighed, dissolved in ethanol, and used as a standard solution. Using the test solution and 30 µl each, the peak area of coenzyme Q10 was determined by testing according to the liquid chromatograph method under the following conditions.

[표 4][Table 4]

구분division 조건Condition 7일7 days 15일15th 30일30 days 45일45 days 실시예 4Example 4 25℃25 ℃ 100%100% 100%100% 98%98% 97%97% 45℃45 ° C 100%100% 100%100% 98%98% 95%95% 비교예 4Comparative Example 4 25℃25 ℃ 100%100% 98%98% 95%95% 86%86% 45℃45 ° C 100%100% 96%96% 89%89% 80%80%

본 발명의 나노유화 조성물은 수소첨가 레시친, 산화방지제로 토코페롤 및 분산매로 글리세린을 포함하고, 고압 호모지나이저를 이용하여 유화시킴으로써, 균일하고 미세한 나노크기의 매우 안정한 유화 조성물을 제공할 수 있다. 따라서, 본 발명의 조성물은 투명하고 점도가 낮기 때문에 스킨류, 로션류 및 크림류 등의 다양한 화장료 제형에 적용이 가능하다.The nanoemulsifying composition of the present invention includes hydrogenated lecithin, tocopherol as an antioxidant and glycerin as a dispersion medium, and emulsified using a high pressure homogenizer, thereby providing a uniform and fine nano-sized, very stable emulsion composition. Therefore, since the composition of the present invention is transparent and low in viscosity, it is applicable to various cosmetic formulations such as skins, lotions and creams.

Claims (5)

코엔자임 Q10 0.01 내지 30 중량%, 유화제인 수소첨가 레시친 1 내지 10 중량%, 산화 방지제로서 토코페롤을 0.1 내지 1.0 중량%, 및 분산매로서 잔량의 글리세린을 포함하는 나노유화 조성물.A nanoemulsion composition comprising 0.01 to 30% by weight of coenzyme Q10, 1 to 10% by weight of hydrogenated lecithin, which is an emulsifier, 0.1 to 1.0% by weight of tocopherol as an antioxidant, and a balance of glycerin as a dispersion medium. 삭제delete 제1항에 따른 조성물을 호모믹서로1차 유화시키고; 및First emulsifying the composition according to claim 1 with a homomixer; And 고압 호모지나이저에 1회 이상 통과시켜 2차 유화시키는 단계2nd emulsification by passing it through the high pressure homogenizer at least once 를 포함하는 나노 유화조성물의 제조방법.Method for producing a nano-emulsion composition comprising a. 제 3항에 있어서, 상기 고압 호모지나이저의 압력이 50~2500 기압인 유화 조성물의 제조방법.The method of claim 3, wherein the pressure of the high pressure homogenizer is 50 to 2500 atmospheres. 삭제delete
KR1020050135139A 2005-12-30 2005-12-30 Nano-emulsion composition using the high-pressure homogenizer KR101151365B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020050135139A KR101151365B1 (en) 2005-12-30 2005-12-30 Nano-emulsion composition using the high-pressure homogenizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050135139A KR101151365B1 (en) 2005-12-30 2005-12-30 Nano-emulsion composition using the high-pressure homogenizer

Publications (2)

Publication Number Publication Date
KR20070071572A KR20070071572A (en) 2007-07-04
KR101151365B1 true KR101151365B1 (en) 2012-06-08

Family

ID=38506689

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050135139A KR101151365B1 (en) 2005-12-30 2005-12-30 Nano-emulsion composition using the high-pressure homogenizer

Country Status (1)

Country Link
KR (1) KR101151365B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100849537B1 (en) * 2007-07-04 2008-07-31 유효경 Nano-emulsion composition of coenzyme q10
KR101157470B1 (en) * 2011-12-05 2012-06-22 재단법인 전라남도생물산업진흥재단 Method for preparing nanoemulsion composition comprising chamaecyparis obtus

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238396A (en) 2002-02-21 2003-08-27 Nisshin Pharma Inc Coenzyme q10-containing emulsified composition
KR100500643B1 (en) 2002-10-28 2005-07-12 주식회사 태평양 Composition for external application to the skin containing jewel ingredients, thereby enhancing absorption into the skin of "NANO-MAX" having a superior anti-oxidantion effect

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238396A (en) 2002-02-21 2003-08-27 Nisshin Pharma Inc Coenzyme q10-containing emulsified composition
KR100500643B1 (en) 2002-10-28 2005-07-12 주식회사 태평양 Composition for external application to the skin containing jewel ingredients, thereby enhancing absorption into the skin of "NANO-MAX" having a superior anti-oxidantion effect

Also Published As

Publication number Publication date
KR20070071572A (en) 2007-07-04

Similar Documents

Publication Publication Date Title
US20080219938A1 (en) SPF compositions
EP1049452A2 (en) Reduced lipid flowable cosmetic or dermatological preparations
KR102053215B1 (en) Composite powder for protecting ultraviolet ray, near infrared ray or blue light, and cosmetics composition containing the same
KR101259452B1 (en) Nanoemulsion emulsifier and cosmetic composition comprising the same
Gangurde et al. Microencapsulation by spray drying of vitamin A palmitate from oil to powder and its application in topical delivery system
JP2004161775A (en) Cosmetic and dermatologic preparation containing vitamin f, complex and mixture comprising cyclodextrin and essential fatty acid, and method for producing the preparation
CN108472227A (en) Novel occlusion composition
WO2012089184A2 (en) Colloidal carrier system with penetration properties for encapsulating lipophilic active agents and oils for topical use
KR101151365B1 (en) Nano-emulsion composition using the high-pressure homogenizer
He et al. Natural food preservation with ginger essential oil: Biological properties and delivery systems
JP2013245205A (en) Skin care composition and cosmetic
KR102177196B1 (en) Nanoparticle multi-layered lamellar niosomes which is formed by nanoparticlation after being formed large niosomes in a supercritical state and cosmetic composition thereof
KR101442799B1 (en) nano suspension-some cosmetic composition in oil containing stabilized L-ascorbic acid or its derivatives, and method for manufacturing the same
CN107028774B (en) Heat stable suspension cosmetic composition
CN112292115A (en) Anti-wrinkle cosmetic composition
Karsli et al. High-Pressure-Homogenized Clove and Thyme Oil Emulsions: Formulation, Stability, and Antioxidant Capacity
KR101904919B1 (en) Method of stabilizing egcg and composition for whitening skin containing egcg
KR101338503B1 (en) Cosmetic composition comprising weighting agent
Kiattisin et al. Preparation and characterization of ultrasound-assisted nanoemulsions containing natural oil for anti-aging effect
Septiyanti et al. Formulation and stability study of fermented soybean extract nanoemulgel
JP2006306819A (en) Sheetlike cosmetic
JP7051494B2 (en) Cosmetics and external skin preparations
JP7112208B2 (en) Cosmetics and external skin preparations
JP7125268B2 (en) Cosmetics and external skin preparations
DE102005024214A1 (en) Cosmetic-/dermatological composition, useful for caring skin or hair, comprises partially neutralized fatty acids esters, esters and ethers of polyethylene glycol, fatty alcohols, thickeners and ascorbic acid and/or ascorbyl compounds

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160411

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20170330

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20190402

Year of fee payment: 8